9/8/2026
Ibogaine and the bicameral mind book release highlights growing interest
Jonathan Dickinson's new book explores ibogaine's therapeutic potential amid rising U.S. policy focus.
Topic archive
maps
2 stories
8/21/2026
Johnson & Johnson invests in Delix Therapeutics
Investment in neuroplastogen company highlights growing interest in non-hallucinogenic psychedelics.